Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.76% rallied 2.86% to $167.63 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.01% falling 1.22% to 4,356.45 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.03% falling 0.19% to 34,297.73. The stock's rise snapped a 10-day losing streak. Johnson & Johnson closed $12.29 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.25% rose 1.46% to $382.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.59% rose 0.80% to $79.46, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +3.59% rose 1.94% to $52.54. Trading volume (13.4 M) eclipsed its 50-day average volume of 7.8 M.